Stock Events

Conduit Pharmaceuticals 

$0.01
15
+$0+5% Thursday 20:00

Statistics

Day High
0.01
Day Low
0.01
52W High
0.01
52W Low
0.01
Volume
1,840
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDTTW. It's not an investment recommendation.
Alphabet
78096
GOOGL
Apple
67979
AAPL
Microsoft
63406
MSFT
Amazon
59137
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap164.39B
Pfizer is a major player in the pharmaceutical industry, directly competing in several therapeutic areas that Conduit Pharmaceuticals targets.
Merck
MRK
Mkt Cap300.25B
Merck operates globally in various pharmaceutical sectors, including those where Conduit Pharmaceuticals has significant investments.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson offers a wide range of pharmaceutical products that compete across multiple segments with Conduit Pharmaceuticals.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Conduit's interests.
AMGEN
AMGN
Mkt Cap179.38B
Amgen focuses on biotechnological medicines, including treatments in areas where Conduit Pharmaceuticals is actively researching.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol-Myers Squibb has a strong portfolio in areas like cancer and cardiovascular diseases, directly competing with Conduit's product lines.
Gilead Sciences
GILD
Mkt Cap98.35B
Gilead Sciences specializes in antiviral drugs and other areas that are key focus points for Conduit Pharmaceuticals.
Novartis
NVS
Mkt Cap244.75B
Novartis is a global healthcare company that produces drugs in direct competition with several of Conduit Pharmaceuticals' products.
Sanofi
SNY
Mkt Cap141.43B
Sanofi operates globally, offering drugs that compete in the same categories as Conduit Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap864.43B
Eli Lilly and Company is involved in pharmaceutical development in areas like diabetes and cancer, competing with Conduit Pharmaceuticals.

About

Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.
Show more...
CEO
Employees
7
Country
US
ISIN
US20678X1147

Listings

XNAS
US
CDTTW
F
DE
ZK7.F
XNAS
US
CDT